Analyst Upgrades:, Inc., Baxter International Inc, and OvaScience Inc

Analysts upwardly revised their ratings and price targets on, Inc. (AMZN), Baxter International Inc (BAX), and OvaScience Inc (OVAS)

by Alex Eppstein

Published on May 10, 2016 at 10:09 AM

Analysts are weighing in on e-tail stock, Inc. (NASDAQ:AMZN), healthcare products producer Baxter International Inc (NYSE:BAX), and fertility firm OvaScience Inc (NASDAQ:OVAS). Here's a quick roundup of today's bullish brokerage notes on AMZN, BAX, and OVAS.

  • AMZN announced the launch of the YouTube-like Amazon Video Direct this morning, and also received a price-target hike at Bernstein to $1,000 from $770 -- all-time-high territory for the shares. Out of the gate, the stock is 2.7% higher at $698.31, bringing its modest year-to-date lead to 3.3% -- but, earlier, it touched a record high of $699.71. Meanwhile, short-term options traders have been more put-skewed than usual toward, Inc. The stock's Schaeffer's put/call open interest ratio (SOIR) of 1.29 ranks in the 83rd percentile of its annual range. Looking ahead, AMZN's annual shareholder meeting is scheduled to take place one week from today.
  • BAX is down 0.4% at $45 -- though it's just below its May 9 record high of $45.52 -- even after the drugmaker upped its earnings outlook for 2018 through 2020. Likewise, the company said it expects to generate a free cash flow of $1.75 billion by the end of the decade. Leerink, Cowen, and UBS responded by upwardly revising their price targets on Baxter International Inc. Future upgrades are a possibility, as well, considering 10 of 11 analysts rate the stock a "hold" or worse. One potential catalyst for more upbeat attention is today's BofA-Merrill Lynch Health Care Conference, with BAX set to make an appearance this afternoon.
  • OVAS has soared 4.9% to trade at $7.42, following a price-target hike to $8 from $7 at Ladenburg Thalmann. That said, since its late-April peak of $11.66, the stock has surrendered 36% of its value, and is now testing a potential layer of resistance in the form of its 80-day moving average. Short sellers may be uneasy amid OvaScience Inc's upside move this morning. A lofty 32.4% of the stock's float is sold short, and it would take over four weeks to cover these positions, based on OVAS' average daily trading volume.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.
Wall Street Reclaims Two Key Trendlines This Week
U.S.-China tensions and dire economic data still weigh, though
Dell Stock Jumps on Upbeat First Quarter
DELL announced an upbeat first-quarter report
The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.